Listen
BONVIVA
-
Opinions on drugs -
Posted on
Jun 21 2006
- Updated on
Nov 28 2006
Reason for request
inclusion on the list of drugs reimbursed by National Health Insurance and approved for hospital use.
-
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
Bonviva 150 mg does not contribute any improvement in actual benefit (level V) over Bonviva 2.5 mg in the treatment of postmenopausal osteoporosis to reduce the risk of vertebral fracture. Efficacy against femoral neck fractures has not been established. |
Contact Us
Évaluation des médicaments
